Three trials of short-acting GLP-1 receptor agonists showed slowed motor decline in Parkinson's disease, though the dedicated EVOKE trial of semaglutide for early Alzheimer's disease did not demonstrate significant benefit
The objectives of this study were to characterize lines of therapy (LOTs), calculate the length of time spent on each LOT, and identify the reasons for the LOT end among patients who initiated oral semaglutide for T2DM
Consultation : We will have a discussion about your weight loss goals, medical history, and lifestyle
C., Chan, A., Dubcenco, E., Li, X., TRAVERSE Study Investigators (2023)
Losartan lows the urate reabsorption by inhibitory activity of URAT1 in the range of clinically relevant concentrations (0.110 nm) (Iwanaga et al., 2007)